Professor of Medicine, University Pennsylvania
Pulmonology
Dr. Milton D. Rossman, MD
|
|
Give Review
Milton D. Rossman, MD practices Pulmonology. He studied medicine at Jefferson Medical College. He over the years received 4 awards: "America's Top Doctors", "Philadelphia Magazine", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Milton Rossman is a published MD. He has 73 papers published. The most current publication "Effects of prolonged oxygen exposure at 1.5, 2.0, or 2.5 ATA on pulmonary function in men (predictive studies V)." He is registered with Medicare.
Publications
- Reliability and Validity of Cutaneous Sarcoidosis Outcome Instruments Among Dermatologists, Pulmonologists, and Rheumatologists.
- Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study (GRADS): Sarcoidosis Protocol.
- Vertical gradients in regional alveolar oxygen tension in supine human Lung imaged by hyperpolarized (3) He MRI.
- Alterations of Regional Alveolar Oxygen Tension in Asymptomatic Current Smokers: Assessment with Hyperpolarized (3)He MR Imaging.
- A variability study of regional alveolar oxygen tension measurement in humans using hyperpolarized (3) He MRI.
- A multislice single breath-hold scheme for imaging alveolar oxygen tension in humans.
- Recent Chronic beryllium disease in residents surrounding a beryllium facility: patients' information.
- Recent Chronic beryllium disease in residents surrounding a beryllium facility.
- Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis).
- Relationship of environmental exposures to the clinical phenotype of sarcoidosis.
- Process-related risk of beryllium sensitization and Disease in a copper-beryllium alloy facility.
- Flow cytometric test for beryllium sensitivity.
- Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium Hypersensitivity.
- Effects of chlormezanone on anxiety and tension: a double blind study.
- A comparison of chlormezanone, meprobamate, and placebo.
- Blood and Lung mononuclear cell inhibition of fibroblast growth in sarcoidosis.
- Bronchoalveolar cell populations in acute sarcoidosis. Observations in smoking and nonsmoking patients.
- Presenting characteristics as predictors of duration of treatment in sarcoidosis.
- Specific DNA amplification utilizing the polymerase chain reaction and random oligonucleotide primers: application to the analysis of antigen receptor variable regions.
- Monocyte Fc gamma receptor recognition of cell-bound and aggregated IgG.
- Dual time point 18F-FDG PET imaging for differentiating Malignant from inflammatory processes.
- Pathogenesis of sarcoidosis. State of the art.
- Bronchoalveolar lymphocytes in sarcoidosis.
- Receptors for the Fc portion of immunoglobulin G (Fc gamma R) on human monocytes and macrophages.
- The immunobiology of human Fc gamma receptors on hematopoietic cells and tissue macrophages.
- The Fc gamma receptors on human macrophages.
- Diagnosis of Pneumocystis carinii Pneumonia by cytologic evaluation of Papanicolaou-stained bronchial specimens.
- Modulation of Fc gamma receptors on the human macrophage cell line U-937.
- Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta ...
- Bronchoalveolar lavage in a patient with Chronic berylliosis: evidence for hypersensitivity pneumonitis.
- Blood cell proliferation response to beryllium: analysis by receiver-operating characteristics.
- Carbohydrate differences in HLA-DR molecules synthesized by alveolar macrophages and blood monocytes.
- Do high glucose levels have differential effect on FDG uptake in inflammatory and Malignant disorders?
- Intense F-18 fluorodeoxyglucose uptake caused by mycobacterium avium intracellulare Infection.
- Quantitative assessment of lung ventilation and microstructure in an animal model of idiopathic Pulmonary fibrosis using hyperpolarized gas MRI.
- Pulmonary sarcoidosis: correlation of serum angiotensin-converting enzyme with blood and bronchoalveolar lymphocytes.
- Nodular endobronchial sarcoidosis: a study comparing blood and Lung lymphocytes.
- Effects of prolonged oxygen exposure at 1.5, 2.0, or 2.5 ATA on Pulmonary function in men (predictive studies V).
- Justification for screening for Chronic beryllium disease: closer to reality.
- Immune complexes in sarcoidosis: a correlation with activity and duration of Disease.
- Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial Lung disease.
- Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
- Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for Chronic beryllium disease.
- Identification of HLA-DRPhebeta47 as the susceptibility marker of Hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA...
- Chronic beryllium disease and sensitization at a beryllium processing facility.
- Chronic beryllium disease: diagnosis and management.
- Beryllium, an adjuvant that promotes gamma interferon production.
- Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS).
- Chronic beryllium disease in a dental laboratory technician.
- Genome-wide search for sarcoidosis susceptibility genes in African Americans.
- HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
- Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back.
- Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests.
- HLA and environmental interactions in sarcoidosis.
- Chronic beryllium disease: a hypersensitivity disorder.
- Clinical characteristics of patients in a case control study of sarcoidosis.
- SKDM human leukocyte antigen (HLA) tool: A comprehensive HLA and Disease associations analysis software.
- Disease-specific changes in gammadelta T cell repertoire and function in patients with Pulmonary tuberculosis.
- Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).
- Genetic markers in beryllium Hypersensitivity.
- Depression in sarcoidosis.
- Sarcoidosis: association with human leukocyte antigen class II amino acid epitopes and interaction with environmental exposures.
- Two year prognosis of sarcoidosis: the ACCESS experience.
- HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.
- Is Chronic beryllium disease sarcoidosis of known etiology?
- A case control etiologic study of sarcoidosis: environmental and occupational risk factors.
- Complications of video-assisted thoracoscopic Lung biopsy in patients with interstitial Lung disease.
- Comparison of sarcoidosis phenotypes among affected African-American siblings.
- Pulmonary and psychosocial findings at enrollment in the ACCESS study.
- The spectrum of biopsy sites for the diagnosis of sarcoidosis.
- A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study.
- A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active Pulmonary sarcoidosis.
Schools
Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University
Philadelphia General Hospital
University Hosps
University Of Pennsylvania
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asbestosis
- Asthma
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
University of Pennsylvania Health System -
Case Western Reserve University - University Hospitals -
Jefferson Medical College
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1982636973 | |
| NPPES Provider LastName | ROSSMAN | |
| NPPES Provider FirstName | MILTON | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 347.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982636973 |
| Last Name Of The Provider | ROSSMAN |
| First Name Of The Provider | MILTON |
| View All |
Similar Doctors
|
|
Dr. Thomas J. Scheuerman, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Bellini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ubaldo J. Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gary A. Aaronson, DO |
|
|
Dr. Leon A. Kauffman, MD |
|
|
Dr. Michael A. Grippi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheilonda R. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aditi Satti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nalaka S. Gooneratne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edmund K. Moon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel T. Kuna, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paul A. Kinniry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra B. Weibel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven R. Russell, MD
This Doctor is OpenDoctor Recommended.
|